SCHEMBL11348388

SCHEMBL11348388

CC1CCCCNC1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24661665 1.00
SCHEMBL22142021 1.00
SCHEMBL22142205 1.00
SCHEMBL22142426 1.00
SCHEMBL22142418 1.00
SCHEMBL12548334 0.97 MAPT (0.36)
SCHEMBL12548465 0.97 MAPT (0.36)
SCHEMBL25143569 0.97 MAPT (0.36)
SCHEMBL22141987 0.92
SCHEMBL26055 0.92

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4124591-A HERBICIDES, PLANT GROWTH REGULATORS BASF AKTIENGESELLSCHAFT (DE) 1978-11-07 US claimed
WO-2020132384-A1 THIENOPYRIDINE INHIBITORS OF RIPK2 CELGENE CORPORATION (US) 2020-06-25 WO disclosed
WO-2017157929-A1 QUINOLINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO THE MODULATION OF THE SEROTONIN 5-HT6 RECEPTOR AbbVie Deutschland GmbH & Co. KG (DE) 2017-09-21 WO disclosed
US-20130281435-A1 THERAPEUTIC AGENT FOR IRRITABLE BOWEL SYNDROME TAKEDA PHARMACEUTICAL COMPANY LIMITED 2013-10-24 US disclosed
US-20130281435-A1 THERAPEUTIC AGENT FOR IRRITABLE BOWEL SYNDROME TAKEDA PHARMACEUTICAL COMPANY LIMITED 2013-10-24 US disclosed
US-20110136788-A1 THERAPEUTIC AGENT FOR IRRITABLE BOWEL SYNDROME TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-06-09 US disclosed
US-20110136788-A1 THERAPEUTIC AGENT FOR IRRITABLE BOWEL SYNDROME TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-06-09 US disclosed
EP-2322222-A1 THERAPEUTIC AGENT FOR IRRITABLE BOWEL SYNDROME Takeda Pharmaceutical Company Limited (JP) 2011-05-18 EP disclosed
WO-2010016552-A1 THERAPEUTIC AGENT FOR IRRITABLE BOWEL SYNDROME 武田薬品工業株式会社 (JP) 2010-02-11 WO disclosed
US-7625887-B2 Receptor agonists TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-12-01 US disclosed
US-7625887-B2 Receptor agonists TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-12-01 US disclosed
US-7217447-B2 Ink-jet recording sheet FUJIFILM CORPORATION (JP) 2007-05-15 US disclosed
US-4283534-A Reductive alkylation of nitrogen heterocycles BASF AKTIENGESELLSCHAFT (DE) 1981-08-11 US disclosed
US-4272282-A ANTIDOTES BASF AKTIENGESELLSCHAFT (DE) 1981-06-09 US disclosed
US-4249933-A N-ETHYL-N-ETHYL-BICYCLO(2.2.1) HEPT-2-YL THIOCARBAMATE AND A HALOACYLAMIDE AS ANTAGONIST; PRE- AND POSTEMERGENCE HERBICIDES BASF AKTIENGESELLSCHAFT (DE) 1981-02-10 US disclosed
EP-0009555-A1 Herbicidal agents based on thiolcarbamate, containing a haloacylamide as antagonist, and their use in a process for selectively controlling the growth of unwanted plants BASF Aktiengesellschaft (DE) 1980-04-16 EP disclosed
EP-0008649-A1 Herbicidal agents comprising acetanilides and N-isopropyl-N-propargyl-dichloracetamide and process for selectively combating undesired plant growth BASF Aktiengesellschaft (DE) 1980-03-19 EP disclosed
US-4124591-A HERBICIDES, PLANT GROWTH REGULATORS BASF AKTIENGESELLSCHAFT (DE) 1978-11-07 US disclosed